IP Library Granted Patent US 7,507,483
Granted Patent B2
US 7,507,483 · App. 10/405,557 · Granted Mar 24, 2009

Enhanced bonding layers on native oxide surfaces

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,507,483
App. No.
10/405,557
Granted
Mar 24, 2009
Kind
B2
Abstract

An implantable device with a metal, metal alloy, metalloid, polymeric or ceramic surface and a phosphonic acid coating layer directly contacting the surface wherein the surface has hydroxyl groups covalently bonded to the acid groups of the coating layer and the phosphonate organic ligands are omega-functionalized.

Claims (15)

1. An implantable device comprising a metal, metal alloy, metalloid, polymeric or ceramic surface with an oxide overlayer, and a phosphonic acid coating layer covalently bonded to the oxide overlayer, wherein said coating layer is formed by coating said oxide overlayer with a self-assembled layer of organophosphonic acid molecules comprising organic ligands containing from about 2 to 20 carbon atoms and heating said coated oxide overlayer so that the organophosphonic acid groups react with said oxide overlayer and bond said self-assembled layer thereto, and the phosphonic acid organic ligands are functionalized at the omega carbons.

2. The implantable device of claim 1 , wherein the oxide overlayer is a native oxide overlayer.

3. The implantable device of claim 2 , wherein the phosphonic acid coating layer is formed by coating the oxide overlayer with a phosphonic acid having the formula H 2 RPO 3 wherein R is an omega functionalized hydrocarbon ligand.

4. The implantable device of claim 2 , wherein the device surface comprises titanium metal or an alloy thereof.

5. The implantable device of claim 1 , wherein the phosphonic acid coating layer is formed by coating the oxide overlayer with a phosphonic acid having the formula H 2 RPO 3 , wherein R is an omega-functionalized hydrocarbon ligand.

6. The implantable device of claim 1 , wherein the device surface comprises titanium metal or an alloy thereof.

7. The implantable device of claim 1 , wherein the device is a dental, medical or orthopedic implant.

8. The implantable device of claim 7 , wherein the orthopedic device is selected from the group consisting of knee replacement devices and hip replacement devices.

9. The implantable device of claim 1 , wherein the omega carbon is directed away from the substrate surface.

10. The implantable device of claim 1 , wherein the ligands are chemically transformed to react and covalently bond to bone protein or osteoconductive proteins or peptides.

11. The implantable device of claim 1 , wherein the phosphonates are functionalized at the omega carbon with groups selected from the groups consisting of amino, carboxylate and thiol groups.

12. An implantable device comprising a metalloid, polymeric or ceramic surface with an oxide overlayer, and a coating layer directly contacting said surface, wherein said coating layer comprises inorganic phosphate groups and said inorganic phosphate layer is formed by coating said oxide surface with a phosphoric acid solution and heating said coated oxide overlayer so that so that said phosphoric acid coating reacts with said oxide overlayer and bonds said phosphoric acid coating thereto, thereby providing an inorganic phosphate coating comprising free hydroxyl groups.

13. The implantable device of claim 12 , wherein the inorganic phosphate layer is functionalized for covalent attachment of bone tissue proteins or osteoconductive proteins or peptides.

14. The implantable device of claim 12 , wherein the inorganic phosphate coating is covalently bonded to the oxide layer.

15. The implantable device of claim 12 , wherein the device is a dental, medical or orthopedic implant.

Assignments (1)
CONFIRMATORY LICENSE Recorded Jun 17, 2010
From: PRINCETON UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 024547/0453 →
Continuity (5)
Continuation In Part 1017974300 · Jun 24, 2002
Continuation In Part 0966808000 · Sep 22, 2000
Provisional Application 6030014400 · Jun 22, 2001
Provisional Application 6015539800 · Sep 22, 1999
Related Publication 20040023048A1 · Feb 5, 2004